NovoLog

Swiss trademark · 450443 · Combined mark · Deleted

Register entry

Registration number
450443
Application number
10343/1997
Status
Deleted
Type
Combined mark
As registered
NovoLog ((fig.))
Filed
Dec 23, 1997
Registered
Mar 23, 1998
Published
Apr 30, 1998
Deleted
Jul 31, 2018
Reason
Not renewed
Priority
25.09.1997 DK
Source
Swissreg

Goods and services

Pharmaceuticals

Antidiabetische Präparate.

Medical devices

Medizinische Apparate und Instrumente zur Behandlung von Diabetes.

Education, entertainment and sport

Ausbildung, Erziehung und Unterricht, bezogen auf Diabetes.

Science, technology and IT

Information und Beratung bezogen auf Diabetes.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 31, 2018

    Deleted, not renewed

    Published in Swissreg on 31.07.2018

  2. Oct 15, 2007

    Renewed

    Published in the SOGC no. 199 of 15.10.2007

  3. Aug 20, 2007

    Agent’s address changed

    Representative
    Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich → Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in the SOGC no. 159 of 20.08.2007

  4. Jun 12, 2006

    Agent entered

    Representative
    R.A. Egli & Co, Patentanwälte, Horneggstrasse 4, 8008 Zürich → Isler & Pedrazzini AG, Postfach 6940, 8023 Zürich

    Published in the SOGC no. 111 of 12.06.2006

  5. Jul 24, 2001

    Holder’s address changed

    Owner
    Novo Nordisk A/S, Novo Allé,, 2880 Bagsvaerd (Dänemark);, Etablissement commercial et adresse pour, la correspondance: Novo Nordisk A/S, c/o Novo Nordisk Ferment AG, Neumatt, 4243 Dittingen → Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, Denmark

    Published in the SOGC no. 141 of 24.07.2001

  6. Apr 30, 1998

    Registered

    Published in the SOGC no. 82 of 30.04.1998

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.